AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.

Journal of Global Infectious Diseases, published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the field of infectious diseases, offering insightful research and critical analyses that contribute to global health discourse. Since its inception as an Open Access journal in 2009, it has aimed to disseminate knowledge on various facets of infectious diseases, fostering collaboration among researchers, clinicians, and public health professionals. With an impact factor indicative of its growing significance—ranked in the Q3 category of Infectious Diseases for 2023—this journal publishes a diverse range of studies, from basic science to clinical applications. Its dedicated contributions help address pressing health challenges and enhance knowledge sharing in an era where infectious diseases pose significant threats worldwide. Based in India, the journal not only highlights regional health issues but also connects to the broader global landscape, making it an essential platform for anyone interested in advancing the field.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

PUBLIC HEALTH NUTRITION is a leading journal published by CAMBRIDGE UNIVERSITY PRESS, focusing on the interdisciplinary field of nutrition as it relates to public health. With its Open Access model established in 2022, the journal ensures widespread dissemination of vital research findings for practitioners, policymakers, and academics alike. Based in the United Kingdom, the journal has been pivotal in bridging gaps between nutrition science and public health initiatives since its inception in 1998. It has consistently ranked in the Q2 quartile across multiple categories, including Medicine (miscellaneous), Nutrition and Dietetics, and Public Health, Environmental and Occupational Health, as per the latest rankings. The journal is indexed in Scopus, underscoring its significance and relevance in the academic community, with impressive rankings that place it in the top percentiles of its category. Dedicated to publishing quality research that informs dietary practices and health policies, PUBLIC HEALTH NUTRITION is an essential resource for researchers, professionals, and students committed to enhancing public health through improved nutritional practices.

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Journal of Geriatric Cardiology, published by TSINGHUA UNIV PRESS, is a pivotal platform for researchers and practitioners dedicated to the intersection of cardiology and geriatrics. Established in 2006, this journal navigates the complexities of cardiovascular health in the elderly, providing a critical forum for advancing knowledge and fostering innovation in this vital area of medicine. With an ISSN of 1671-5411, it holds an emerging position, currently ranked in the third quartile of both Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology categories as of 2023. Furthermore, its Scopus rankings reflect its growing influence, especially in the fields of Cardiology (ranked #185 out of 387) and Geriatrics (ranked #69 out of 116). Although the journal is not open access, it offers a valuable repository of peer-reviewed articles that contribute significantly to current discourse and clinical practices in geriatrics and cardiovascular care. Situated in Beijing, China, this journal stands as an important resource for professionals, researchers, and students aiming to enhance their understanding and address the challenges faced in the care of older adults.

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Ophthalmic Epidemiology, published by Taylor & Francis Inc, stands as a crucial platform in the fields of ophthalmology and epidemiology, with the journal's pivotal contributions recognized in its esteemed category quartiles, ranking Q1 in Ophthalmology and Q2 in Epidemiology for 2023. Since its inception in 1994, the journal has provided a multidisciplinary approach to understanding the distribution and determinants of ocular diseases, thereby informing public health practices and clinical interventions. With a commitment to disseminating high-impact research, it holds a Scopus rank of #45/137 in Ophthalmology and engages a global audience of researchers, practitioners, and students dedicated to advancing the field. Although it is not an open-access journal, Ophthalmic Epidemiology remains a vital resource for innovative studies and reviews that help shape evidence-based strategies to combat vision-related public health issues.

AIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.